New devices assist in vision restoration
August 15th 2011Sensory substitution devices are in development as vision restoration technology for the blind, but a lack of accepted standards for screening users and evaluating their performance represents an important impediment to the ultimate of clinical success of these platforms.
Imaging method for ocular diseases uses new approach
August 15th 2011Quantitative in vivo assessment of retinal blood flow attained with ultra-high-speed swept source/Fourier-domain optical coherence tomography could be beneficial for assessing pathologic changes in ocular diseases associated with abnormalities in retinal blood flow.
Ford 'Super Vision Center' opens
August 10th 2011The Henry Ford OptimEyes Super Vision Center has opened in the new Henry Ford Medical Center. The 140,000-square-foot facility includes 65,000 square feet of space for the Henry Ford OptimEyes Super Vision Center, with the remaining space expected to be leased out to private-practice physicians.
Results: Bromfenac same as placebo
August 10th 2011Initial top-line results from a Phase III study of bromfenac ophthalmic solution (Remura, ISTA Pharmaceuticals) indicate that bromfenac was not statistically superior to placebo in treating one sign and one symptom of dry eye disease. ISTA announced this result from the WEST study, the first of two phase III safety and efficacy studies being conducted under a special protocol assessment (SPA) agreed upon with the FDA.